What is Survanta (animal-based) and what is it used for?
Survanta is a brand name for a lung surfactant medicine used to treat respiratory distress syndrome (RDS) in premature newborns. It replaces or supplements the surfactant that helps keep air sacs in the lungs open and allows easier breathing.
Is Survanta made from animals?
Yes. Survanta is derived from animal lung material (commonly described as bovine sources in medical references for this product class). That animal-derived surfactant is processed into a therapeutic form for infants who need it.
How is Survanta given?
Survanta is given by direct instillation into the trachea (an airway delivery method used in NICU settings) so it can reach the lungs where surfactant is needed.
What risks or side effects do people ask about?
Parents and clinicians commonly focus on risks tied to administering surfactant to very small, critically ill newborns, such as breathing and oxygenation changes around the time of dosing. Specific side effects depend on the infant’s condition and dosing schedule, and should be discussed with the neonatal care team.
Are there non-animal alternatives?
Surfactant replacement therapy is available in different formulations worldwide. Some products are animal-derived (like Survanta), while others use different manufacturing approaches (including synthetic or other source types), depending on the country and approvals.
Sources
No reliable sources were provided in your message, so I can’t cite specifics about Survanta’s exact animal source, formulation details, or prescribing information. If you share the country/label you mean (or paste a link or prescribing text), I can give a precise, sourced answer about the “animal” aspect and clinical use.